autoimmune therapy (ALERT B&C)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautoimmune therapy (ALERT B&C)
Drug Alias NameGNXDC series (ALERT B&C)GNXDC series (Genomics One)autoimmune therapy (Genomics One)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesALERT B&C Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesALERT B&C Corp
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A